{Reference Type}: Journal Article
{Title}: New Potential Biomarkers for Chronic Kidney Disease Management-A Review of the Literature.
{Author}: Lousa I;Reis F;Beirão I;Alves R;Belo L;Santos-Silva A;
{Journal}: Int J Mol Sci
{Volume}: 22
{Issue}: 1
{Year}: Dec 2020 22
{Factor}: 6.208
{DOI}: 10.3390/ijms22010043
{Abstract}: The prevalence of chronic kidney disease (CKD) is increasing worldwide, and the mortality rate continues to be unacceptably high. The biomarkers currently used in clinical practice are considered relevant when there is already significant renal impairment compromising the early use of potentially successful therapeutic interventions. More sensitive and specific biomarkers to detect CKD earlier on and improve patients' prognoses are an important unmet medical need. The aim of this review is to summarize the recent literature on new promising early CKD biomarkers of renal function, tubular lesions, endothelial dysfunction and inflammation, and on the auspicious findings from metabolomic studies in this field. Most of the studied biomarkers require further validation in large studies and in a broad range of populations in order to be implemented into routine CKD management. A panel of biomarkers, including earlier biomarkers of renal damage, seems to be a reasonable approach to be applied in clinical practice to allow earlier diagnosis and better disease characterization based on the underlying etiologic process.